Medtronic - MITG

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Medtronic - MITG sits in the top decile of US sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count).

119 total trials 5 currently recruiting 99 completed top decile by trial count

Medtronic - MITG: 119 sponsored US clinical trials, 5 recruiting.

Medtronic - MITG sponsors 119 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 99 completed. 5 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypoxia, with 3 trials.

Top-decile sponsor footprint

Medtronic - MITG ranks in the top decile of sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 67/100

99 of 109 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

119 total, page 2 of 3

COMPLETED NA

Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable

NCT02265783

TERMINATED NA

Hemodynamic Response During Goal Directed Fluid Therapy in the OR

NCT02365688

COMPLETED

Controlled Acute Hypoxia Study - Abbreviated Sensor Line

NCT02216344

COMPLETED

Assuring and Defining Outcomes Through Procedural Training Using a Proctorship Model That Collects Patient Outcomes A Single-Arm, Case-Series to Determine the Feasibility of Safe Skills Transfer for Laparoscopic Ventral Hernia Repair Utilizing a Hands-On Proctorship Model.

NCT02238743

COMPLETED NA

A Safety and Tolerability of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial Neoplasia

NCT02189161

TERMINATED NA

Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis

NCT02022826

COMPLETED

Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0

NCT02075398

COMPLETED

Bedside Respiratory Patient Monitoring System - Sensor Off Study

NCT02075346

COMPLETED NA

Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects

NCT01942720

COMPLETED NA

Use of Radiofrequency Ablation for RGB Salvage

NCT01910688

COMPLETED

Respiration Rate Monitoring During Transitions

NCT01881269

COMPLETED

A Prospective Study in Patients Undergoing Primary Ventral Hernia Repair Using Parietex™ Composite Ventral Patch

NCT01848184

COMPLETED

Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly) NEO/PEDS

NCT01797250

TERMINATED NA

Radial Reload Open LAR Case Series

NCT01717014

COMPLETED NA

Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids

NCT01841970

TERMINATED Phase 4

Radial Reload Laparoscopic LAR Case Series

NCT01706822

COMPLETED

Respiration Rate V2.0 in a Hospital Setting

NCT01837537

COMPLETED NA

A Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation System

NCT01970787

COMPLETED

Respiration Rate V2.0 in Healthy Volunteers

NCT01804062

COMPLETED

Pulse Oximetry_Performance During Severe Signal Interference - PCBA-1 (Printed Circuit Board Assembly)

NCT01747473

COMPLETED

Pulse Oximetry- Evaluating Resp Rate- PCBA-1

NCT01791582

COMPLETED

Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly)

NCT01747460

COMPLETED

Pulse Oximetry- Evaluating Sensor Off- PCBA-1

NCT01791569

COMPLETED

Pulse Oximetry- Performance During Severe Signal Interference

NCT01720355

COMPLETED Phase 1

PillCam® Platform With the PillCam Crohn's Disease Capsule

NCT01631435

COMPLETED NA

The Influence of Endotracheal Tube Design on Fluid Leakage Into the Lungs During Surgery

NCT01539135

COMPLETED Phase 1

Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients

NCT01576120

COMPLETED Phase 1

Safety Evaluation of Bowel Cleansing Regimen for PillCam® COLON 2 Capsule Endoscopy

NCT01575093

COMPLETED NA

Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon

NCT01372878

COMPLETED

Novel Non-Invasive Monitoring Parameter in a Hospital Setting

NCT01306201

COMPLETED

Novel Non-Invasive Monitoring Parameter in Healthy Volunteers

NCT01294514

COMPLETED NA

Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids

NCT01306877

COMPLETED NA

Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon

NCT01269372

COMPLETED NA

ENDO GIA™ Stapler With ENDO GIA™ Reload With Tri-Staple™ Technology in a Pulmonary Resection

NCT01241565

COMPLETED

A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects

NCT01214252

COMPLETED Phase 2

Evaluation of PillCam® Colon 2 Capsule Endoscopy Regimen

NCT01185002

COMPLETED NA

Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure

NCT01169311

COMPLETED

Removing Fluid Above Breathing Tubes in the Operating Room

NCT01110109

COMPLETED

Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor

NCT01082575

COMPLETED NA

Tri Staple Technology Stapler Used in Gastric Bypass

NCT01026103

COMPLETED

Oxygen Saturation Alarms in the Neonatal Intensive Care Unit

NCT01085539

COMPLETED NA

Safety and Efficacy Study of Duet TRS

NCT00950872

COMPLETED NA

Evaluation of PillCam® Express Capsule Endoscopy Delivery System

NCT01088646

COMPLETED

Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge

NCT00998374

COMPLETED NA

Evaluation of Dermal Closure With an Absorbable Barbed Suture as Compared to a Conventional Absorbable Suture

NCT00959374

COMPLETED

Oxygen Saturation Monitoring During Surgery

NCT01098851

COMPLETED NA

Evaluation of PillCam™ Colon 2 in Visualization of the Colon

NCT01087528

TERMINATED Phase 2

Feasibility of Permacol Use in Infected Fields

NCT00820040

COMPLETED NA

The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

NCT01450813

TERMINATED

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

NCT00912366

← Previous Page 2 of 3 Next →

What is open in the Medtronic - MITG pipeline

5 recruiting of 119 indexed (4% open); 99 completed (83%).

Phase mix: 5 late (III/IV) vs 5 early (I/II) (balanced across stages).

Top condition: Hypoxia (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medtronic - MITG: open-pipeline peers nationwide

Peers matched on 119 registered trials and 4% open enrollment, not the therapeutic-area sidebar.

Medtronic - MITG sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400 0%10%20%30%40% Total trials Recruiting share Medtronic - MITGChildren's Hospital Los AngelesJaeb Center for Health ResearchMichigan State UniversitySan Diego State UniversityNational Institute on Drug Abuse (NIDA)Akebia TherapeuticsDentsply Sirona Implants and ConsumablesSmith & Nephew
Medtronic - MITG sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medtronic - MITG sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 119 trials (± recruiting share)

Sponsors near 4% open enrollment (± trial volume)

What to do with this Medtronic - MITG page

119 registered trials is a research-attention snapshot, not an endorsement of Medtronic - MITG or any single study.

  • 5 of Medtronic - MITG's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypoxia is the condition Medtronic - MITG studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypoxia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Medtronic - MITG pipeline card: 119 registered trials from official public datasets.Report a data error.